BAG3 is aberrantly expressed in several solid tumors and germ cell leukemias (62, 63), and has been proposed as a potential therapeutic target in cancers including glioma, pancreatic cancer, and ovarian carcinoma. This evidence concerns the gene BAG3 and pancreatic neoplasm.